Copanlisib (trade name Aliqopa), is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies...Wikipedia
Manufacturer's Website: Aliqopa Average retail cost: *
*This drug is administered by your healthcare practitioner, which usually means it may be expensive.